DCM
EVH icon

Delpha Capital Management’s Evolent Health EVH Stock Holding History

Delpha Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-332
Closed -$4K – 464
2017
Q4 		$4K Buy
+332
New +$4.68K ﹤0.01% 1338

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
FG
Formula Growth Montreal, Quebec, Canada $284M AUM 54.56% 1-Year Est. Return

Delpha Capital Management's EVH Position: Q1 2018 in Review

Delpha Capital Management sold out of Evolent Health (EVH) in Q1 2018, closing a stake of 332 shares — an estimated $4K sold.

Delpha Capital Management first reported a position in EVH in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 152 funds tracked by Wall St. Rank hold EVH as of Q1 2018.

  • Delpha Capital Management reported no remaining Evolent Health position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 332 Evolent Health shares in Q1 2018, an estimated $4K.
  • Delpha Capital Management first reported a position in Evolent Health in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Evolent Health position peaked at $4K in Q4 2017.
  • 152 funds tracked by Wall St. Rank held Evolent Health as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.